InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Calise Chris. Director active across 1 company, notably Coeptis Therapeutics Holdings, Inc.. Aggregated, 1 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €8k. History available since 23 August 2023. The latest transaction was disclosed on 23 August 2023 (Acquisition). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration